MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome, in a short open reading frame of the 12S ribosomal RNA gene. Laboratory studies use it to examine mitochondrial-to-nuclear signalling, cellular metabolic stress responses and AMP-activated protein kinase (AMPK) pathways in cell culture and animal models. As one of the first characterised mitochondrial-derived peptides, it is also a case study in how small open reading frames expand the coding capacity of mitochondrial DNA. This article summarises its structure, proposed mechanisms, the published research areas and the analytical and storage standards needed for reproducible work. It is written for laboratory researchers and offers no guidance on human use.
What is MOTS-c?
MOTS-c, short for mitochondrial open reading frame of the twelve S rRNA type-c, is classified as a mitochondrial-derived peptide. Its sequence is Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg, usually written MRWQEMGYIFYPRKLR. The molecular formula is approximately C101H152N28O22S2 and the molecular weight is about 2174 Da for the free peptide. The sequence is notable for its mix of properties. It carries four basic residues, two arginines near the ends and one in the middle together with a lysine, alongside a hydrophobic and aromatic core of tryptophan, tyrosine, phenylalanine and isoleucine, which gives it an amphipathic character that influences solubility and aggregation.
The peptide was described in 2015 by Changhan Lee, Pinchas Cohen and colleagues at the University of Southern California, in a paper in Cell Metabolism. They identified the short open reading frame within the mitochondrial 12S rRNA gene, showed that it is translated into a peptide, and reported that it acted on cellular metabolism. The finding followed the earlier discovery of humanin, a peptide from the 16S rRNA gene, and it supported the idea that mitochondrial DNA encodes more bioactive products than the 13 canonical proteins of the respiratory chain.
Several points of nomenclature are worth noting. The name is written as MOTS-c, MOTS-C and MOTSc, and the “c” is part of the gene-family naming and not a chain label. The product sold by suppliers is a synthetic peptide made by solid-phase synthesis, not an isolated natural product, so it should not be assumed to carry any modifications that the endogenous peptide may have. Whether endogenous MOTS-c is post-translationally modified in cells is not fully settled.
Regulatory context matters for any UK buyer. MOTS-c is not authorised as a medicine in the United Kingdom, and the Medicines and Healthcare products Regulatory Agency (MHRA) has issued warnings about unlicensed products marketed for human use. Researchers should also check current anti-doping lists for any compound used in sport-related analytical work. The material is relevant here only as a laboratory research reagent.
Mechanism of action
Unlike many research peptides, MOTS-c has no well-established cell-surface receptor. The literature describes an intracellular and nuclear mode of action, and this is the most unusual thing about it.
The first proposed mechanism involves the folate cycle and AMPK. In the original 2015 study, the authors reported that MOTS-c inhibited the folate cycle and de novo purine biosynthesis in cultured cells, which caused accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an endogenous activator of AMPK. AMPK is a cellular energy sensor, and its activation shifts metabolism towards energy-producing pathways. This is a description of signalling in the cell lines and mouse tissues studied.
The second proposed mechanism is nuclear translocation. A 2018 paper by Kim and colleagues in Cell Metabolism reported that under metabolic stress, MOTS-c moved from the cytoplasm into the nucleus in cultured cells, where it was reported to interact with transcription factors and to influence the expression of genes involved in stress and antioxidant responses. This positions the peptide as a messenger in communication from mitochondria to the nucleus, a type of signalling called retrograde signalling.
The third area concerns cellular stress and mitochondrial function. Studies in cell lines and rodents have reported that exposure to the peptide altered mitochondrial respiration and stress-response markers, though the effects depend on cell type, concentration and the stress applied.
How an exogenous peptide of this size and charge enters cells is not fully resolved, and this is a real limitation for experimental design. Cellular uptake may depend on the cell type and on concentration, and results obtained by applying synthetic peptide to culture medium cannot automatically be equated with the actions of the endogenous peptide produced inside mitochondria.
For laboratory design, the practical consequence is that controls matter. Vehicle controls, scrambled-sequence peptides and measurement of intracellular peptide where possible help to separate specific effects from artefacts. In cell-based work, “dosage” means molar concentration in the medium, which depends on net peptide content, adsorption to plasticware and protease activity in any serum used.
What the research shows
The literature on MOTS-c is young and concentrated in a small number of research groups. Four areas are summarised below in general terms. Readers should consult the primary papers for methods, concentrations and statistics, because commercial summaries often overstate findings.
The first area is the original characterisation. Lee and colleagues reported in 2015 that MOTS-c was encoded in mitochondrial DNA, was expressed in tissues, and acted on metabolic signalling through the folate cycle and AMPK pathway in cell culture and in mice. Exposures in the mouse experiments were expressed per kilogram of body weight and depended on the route, so the values should be taken from the primary paper. The work can be located through a PubMed search for the original MOTS-c characterisation paper.
The second area is nuclear translocation and gene regulation. The 2018 paper by Kim and colleagues examined MOTS-c in cultured cells exposed to metabolic stress and reported nuclear localisation and effects on gene expression, with AMPK and the stress-response transcription programme involved. This work established the concept of a mitochondrially encoded peptide acting in the nucleus. It can be explored through a PubMed search on MOTS-c nuclear translocation and gene expression.
The third area is skeletal muscle biology in animals. Work published in 2021 by Reynolds and colleagues in Nature Communications reported that MOTS-c levels in mouse and human muscle changed in response to exercise and described effects on muscle-cell gene expression and signalling in mice. These are rodent and cell findings, described here only as part of the scientific record. They carry no implication for people, and nothing in this article suggests a use outside the laboratory.
The fourth area is the genetics and biology of the mitochondrial genome more broadly. Studies of mitochondrial DNA variants, including variants within the MOTS-c coding region reported in some human populations, have examined associations with metabolic traits. Association studies cannot establish causation, and they say nothing about research-grade peptide.
A recurring limitation runs through this body of work. Most studies come from a small number of laboratories, endogenous peptide levels are difficult to measure accurately, and results from synthetic peptide applied to cells may not mirror the natural biology. Reproducibility therefore depends on knowing exactly what material was used.
Research applications
In the laboratory, MOTS-c is used in several contexts. The most common is cell culture work on metabolic signalling, where it is a test compound in studies of AMPK activation, glucose handling, mitochondrial respiration and stress responses in cell types such as myotubes, adipocytes and hepatocyte lines. Good practice is to run a concentration series with a scrambled-sequence control.
A second context is the study of mitochondrial-nuclear communication. MOTS-c is used as a model for how small peptides encoded in mitochondrial DNA relocate within the cell and influence transcription, and it features in work comparing mitochondrial-derived peptides such as humanin.
A third context is animal models of metabolic signalling, which require institutional ethical review and, in the United Kingdom, authorisation under the Animals (Scientific Procedures) Act 1986. Study design should include vehicle controls, blinded assessment and analytical confirmation of the material administered.
A fourth context is analytical chemistry. A 16-residue peptide with two oxidation-prone methionines and several aromatic residues is a useful test case for liquid chromatography and mass spectrometry methods, and reference material of defined identity and purity supports method development and the detection of unlicensed peptide products.
Purity, storage and handling
A 16-residue peptide with a hydrophobic core and several arginines can present synthesis and purification challenges. Arginine residues carry bulky protecting groups that can leave adducts, the tryptophan is vulnerable to modification during cleavage, and the two methionines can oxidise at any stage. Reversed-phase high-performance liquid chromatography (HPLC) with UV detection at 214 or 220 nm is the standard purity method, and a main peak of at least 98 per cent is commonly expected for cell signalling work. The tryptophan and tyrosine residues also absorb at 280 nm, so a second wavelength helps to identify the peptide and to detect impurities lacking aromatic groups. A stated purity is meaningful only if the method and chromatogram are available.
HPLC must be paired with mass spectrometry. The expected mass is about 2174 Da. A species 16 Da higher indicates one oxidised methionine and 32 Da higher indicates two, and because oxidation can arise during storage, the mass spectrum is also a useful check on a vial’s history. A clean peak at the wrong mass is a clean peak of the wrong compound.
A batch-specific certificate of analysis matters because purity and peptide content vary between synthesis runs. It should carry a lot number matching the vial, the HPLC trace or purity value, the observed and theoretical masses, the test date and ideally the salt form and net peptide content. Lyophilised powders contain counterions and residual water, so the weighed mass is not the mass of peptide, and ignoring this introduces systematic errors into any concentration-response comparison. Peptides purified with trifluoroacetic acid are normally supplied as TFA salts, and the counterion is not biologically neutral at every concentration, which matters in cell assays.
Because the methionine residues oxidise readily once the peptide is in solution, batch-level verification matters more here than with a more robust sequence. UK laboratories sourcing Mots-c should expect a batch-specific certificate of analysis that states the mass found and the salt form, with lyophilised storage at -20°C, and the same documentation standard applies when weighing any best peptides supplier uk claim, since a supplier’s analytical record rather than its search ranking shows whether the vial matches its stated specification.
Lyophilised MOTS-c is generally stored at -20°C in a sealed container with desiccant, and many laboratories use -80°C for long-term archives. Vials should reach room temperature before opening so that condensation does not form on the cold powder. After reconstitution, stability falls. Standard practice is to dissolve the peptide in sterile water or a suitable buffer, divide the solution into single-use aliquots and freeze them to avoid repeated freeze-thaw cycles. Refrigerated storage at 2 to 8°C is sometimes used for solutions consumed within days, but the acceptable period should be validated for the assay concerned, preferably by re-running HPLC and mass spectrometry on stored solution. The amphipathic character can promote aggregation at high concentration, so working stocks should be prepared at the lowest practical concentration, and degassed buffers can slow methionine oxidation.
Light sensitivity is a real concern for this sequence. The tryptophan, tyrosine and phenylalanine residues can undergo photo-oxidation, so amber vials or dark storage are advisable, and prolonged exposure to bright laboratory lighting should be avoided. Peptides also adsorb to glass and some plastics at low concentrations, so low-bind tubes are preferred for dilute working solutions.
Labelling is a final indicator of quality. Clear naming, sequence, molecular weight, lot number, salt form and an unambiguous research-only statement suggest a supplier that understands its market, while any wording that implies use in humans is a warning sign and raises regulatory concerns in the United Kingdom.
Frequently asked questions
What is MOTS-c used for in laboratory research?
It is used as a test compound in cell culture studies of AMPK signalling, mitochondrial function and mitochondrial-to-nuclear communication, and in approved animal models of metabolic signalling. It is a research reagent and not an authorised medicine in the United Kingdom.
What is the sequence and molecular weight of MOTS-c?
MOTS-c is a 16-residue peptide with the sequence MRWQEMGYIFYPRKLR and a molecular weight of about 2174 Da. It is encoded in the mitochondrial 12S rRNA gene. The certificate of analysis should show a mass spectrometry result matching this value.
How should MOTS-c be stored for research?
Keep lyophilised peptide at -20°C, or -80°C for long-term archiving, in a sealed, dry, light-protected container. Allow vials to reach room temperature before opening. After reconstitution, aliquot and freeze the solution to limit freeze-thaw cycles and methionine oxidation.
How can I verify the purity of a MOTS-c batch?
Request a batch-specific certificate of analysis showing HPLC purity and a mass spectrometry result near 2174 Da, with the salt form and a lot number matching the vial. For critical work, independent testing by an accredited analytical laboratory confirms identity and purity.
MOTS-c is supplied for in-vitro laboratory research only and is not intended for human or veterinary use.
Research material from Peptides Lab UK: MOTS-c for laboratory research (UK dispatch, batch certificate of analysis, research use only).
